Microtopographical effects of natural scaffolding on cardiomyocyte function and arrhythmogenesis
Introduction
Cardiac tissue is terminally differentiated and therefore has limited repair and regeneration ability in the event of disease or injury. Cardiovascular disease, more specifically ischemic heart disease, remains a leading cause of death for adults throughout the world [1]. Definitive care usually requires whole heart transplantation, but the insufficiency of donor organs necessitates another approach. One alternative is a surgical technique, the Dor procedure, in which infarcted myocardium is replaced with an inert patch [2]. Typically, the patch is composed of biologically inert woven polyethylene terephthalate fibers (Dacron) [3]. Dacron is well tolerated by the body, has high tensile strength and high resistance to stretching and degradation in wet and dry forms [4]. However, Dacron’s limitations include mineralization, fibrosis, risk of infection and its inability to become a functional constituent of the heart portion it replaces [5]. These drawbacks are shared by other synthetic scaffolds, precluding full integration within the cardiac muscle. Therefore, an alternative material that is biocompatible, biodegradable and can be replaced by host-derived tissue to restore cardiac function is in demand.
A potential candidate is natural scaffolding derived from an extracellular matrix (ECM). ECM serve as natural scaffolds for all organ and tissue growth; they are composed of various structural and functional proteins, growth factors, glycosaminoglycans and cytokines [6] arranged in a three-dimensional architecture which facilitates cell maturation. The composition and topography of ECM are essential in determining specificity, cellular structure, organization and function. Finally, ECMs’ natural self-degradation allows regenerated tissue to exist on its own after maturation [5].
Naturally derived scaffolding with little to no immunological response can be prepared by careful removal of overlying tissue and cells to preserve ECM structure and composition. Various tissue types have been repaired with such natural scaffolding, including the lower urinary track, the esophagus, dura matter, blood vessels and musculotendinous tissues [5]. In fact, ECM scaffolding has been previously reported to outperform Dacron and ePTFE as a ventricular patch, and to aid in the improvement of overall heart function [7], [8], [9].
There are currently two commercially available acellular ECM scaffold materials: one is derived from porcine urinary bladder (UBM) (A-Cell, Jessup, MD), and the other porcine jejunum small intestinal submucosa (SIS) (Cook Biotech, West Lafayette, IN). SIS is rich in epithelial cells, tends to be well vascularized and is composed primarily of type I collagen [5]. UBM is extracted from the region below the smooth muscle cells along the lining of the bladder, and is composed mostly of type IV collagen, laminin and entactin [10]. Of the structural proteins, cardiomyocytes adhere most readily to collagen IV and laminin [11]. Furthermore, the growth factors within UBM include VEGF [12] and PDGF [13], which are critical for induction of angiogenesis, especially essential for highly oxygen-demanding heart tissue.
Another characteristic of UBM which may support heart tissue growth is its structure, composed of two different sides: one with a mesh of random fibers (abluminal side) and the other a flat base (luminal side). This is in contrast to Dacron’s regular woven surface (Fig. 1). UBM’s “loose” and fine fiber configuration with high porosity results in a high surface-to-volume ratio and thus potentially larger surface area for cell growth. These characteristics are suspected to play a significant role in enhancing cell adhesion and packing [14], thus promoting high cell density – essential for electrical and mechanical synchronization within cardiac tissue.
Based on these qualifications, it was hypothesized that UBM may serve as a suitable scaffolding material for engineering cardiac tissue. The authors set out to determine whether UBM could provide the environment needed for electrical stability, and whether functional response of the cardiomyocytes is sensitive to the architecture of the two UBM sides.
Section snippets
Material preparation and cell culture
Acellular UBM was purchased from A-Cell (A-Cell Jessup, MD). UBM scaffolds were cut under sterile conditions to 6 × 12 mm scaffolds and were plated with neonatal cardiac myocytes on either the luminal (L) or abluminal (Ab) side. Primary myocyte culture was done as previously described [15], [16], [17]. Briefly, cells were isolated from 2–3-day-old rat pups by trypsin (US Biochemicals, Cleveland, OH) and collagenase (Worthington Biomedical, Lakewood, NJ) enzyme digestion. After centrifugation, the
Results and discussion
The first aim of this study was to assess whether cardiomyocytes could successfully grow on UBM to form connected networks and simulate tissue formation in vitro. The second aim was to determine whether the distinct local microtopography of the two sides of UBM scaffolding affects the growth and function of the cardiomyocytes. This information could be used to guide future scaffold design and ultimately for proper surgical implantation of the matrix for heart repair, particularly in cases with
Conclusions
Overall, the data indicate compatibility of the UBM matrix with cardiomyocytes and support its potential for cardiac applications. While both sides supported the growth of well-connected cells with mature sarcomeric organization, an important finding here is that cardiomyocytes grow and function differently on the two sides of the UBM matrix, with the luminal side promoting more desirable functional properties. These results suggest that surface differences may be leveraged to engineer desired
Acknowledgments
The authors wish to thank Chiung-yin Chung for cell culture and help with manuscript editing, and Dr. Perena Gouma for contributing the SEM pictures of Dacron and unplated UBM. This work was supported in part by grants from The National Science Foundation (BES-0503336), The Whitaker Foundation (RG-02-0654) and the American Heart Association (0430307N).
References (34)
- et al.
Surgical ventricular restoration in the treatment of congestive heart failure due to post-infarction ventricular dilation
J Am Coll Cardiol
(2004) - et al.
Endothelial cell adherence to small intestinal submucosa: an acellular bioscaffold
Biomaterials
(1999) - et al.
Fibronectin peptides mediate HMEC adhesion to porcine-derived extracellular matrix
Biomaterials
(2002) The extracellular matrix as a scaffold for tissue reconstruction
Semin Cell Dev Biol
(2002)- et al.
Functional cardiac cell constructs on cellulose-based scaffolding
Biomaterials
(2004) - et al.
Atrial fibrillation developing in the acute phase of myocardial infarction. Prognostic implications
Chest
(1976) - et al.
Ventricular arrhythmias
Prim Care
(2000) - et al.
A new technique to expand human mesenchymal stem cells using basement membrane extracellular matrix
Biochem Biophys Res Commun
(2004) - et al.
Marrow-derived cells populate scaffolds composed of xenogeneic extracellular matrix
Exp Hematol
(2001) - et al.
Electrospun fine-textured scaffolds for heart tissue constructs
Biomaterials
(2005)
Left ventricular pseudoaneurysm after sutureless repair of subacute left ventricular free wall rupture: a case report
Ann Thorac Cardiovasc Surg
Extracellular matrix for myocardial repair
Heart Surg Forum
Extracellular matrix scaffold for cardiac repair
Circulation
The basement membrane component of biologic scaffolds derived from extracellular matrix
Tissue Eng
Tissue-engineered myocardial patch derived from extracellular matrix provides regional mechanical function
Circulation
Interaction of the extracellular matrix with cardiac myocytes during development and disease
Cited by (12)
3D functional scaffolds for cardiovascular tissue engineering
2018, Functional 3D Tissue Engineering Scaffolds: Materials, Technologies, and ApplicationsThe effect of detergents on the basement membrane complex of a biologic scaffold material
2014, Acta BiomaterialiaCitation Excerpt :Scaffolds containing a BMC are used in a variety of pre-clinical and clinical applications [31–40]. Some of these scaffolds are seeded with cells before use [41–43]. Examples of ECM scaffolds with a BMC structure include several dermal ECM products, such as Alloderm™ and Strattice®, urinary bladder matrix such as MatriStemTM, and virtually all three-dimensional whole organ scaffolds such as liver [10,12,14,44–46], lung [6,15,17] and kidney [16,47–50].
Maternal-engineered nanomaterial exposure disrupts progeny cardiac function and bioenergetics
2017, American Journal of Physiology - Heart and Circulatory PhysiologyApplication of finite element analysis for nanobiomedical study
2017, Computational Finite Element Methods in NanotechnologyTissue engineering strategies for myocardial regeneration: Acellular versus cellular scaffolds?
2016, Tissue Engineering - Part B: Reviews